Literature DB >> 22566502

Linking placental ischemia and hypertension in preeclampsia: role of endothelin 1.

Eric M George1, Joey P Granger.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22566502      PMCID: PMC3401286          DOI: 10.1161/HYPERTENSIONAHA.112.194845

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


× No keyword cloud information.
  62 in total

1.  Agonistic angiotensin II type 1 receptor autoantibodies in postpartum women with a history of preeclampsia.

Authors:  Carl A Hubel; Gerd Wallukat; Myles Wolf; Florian Herse; Augustine Rajakumar; James M Roberts; Nina Markovic; Ravi Thadhani; Friedrich C Luft; Ralf Dechend
Journal:  Hypertension       Date:  2007-01-08       Impact factor: 10.190

2.  Recombinant vascular endothelial growth factor 121 infusion lowers blood pressure and improves renal function in rats with placentalischemia-induced hypertension.

Authors:  Jeffrey S Gilbert; Joseph Verzwyvelt; Drew Colson; Marietta Arany; S Ananth Karumanchi; Joey P Granger
Journal:  Hypertension       Date:  2009-12-21       Impact factor: 10.190

Review 3.  Animal models of pre-eclampsia.

Authors:  Neroli Sunderland; Annemarie Hennessy; Angela Makris
Journal:  Am J Reprod Immunol       Date:  2010-12-06       Impact factor: 3.886

4.  The relationship between serum nitrate and endothelin-1 concentrations in preeclampsia.

Authors:  S Nishikawa; A Miyamoto; H Yamamoto; H Ohshika; R Kudo
Journal:  Life Sci       Date:  2000-08-11       Impact factor: 5.037

5.  Expression and relationship between endothelin-1 messenger ribonucleic acid (mRNA) and inducible/endothelial nitric oxide synthase mRNA isoforms from normal and preeclamptic placentas.

Authors:  M Napolitano; F Miceli; A Calce; A Vacca; A Gulino; R Apa; A Lanzone
Journal:  J Clin Endocrinol Metab       Date:  2000-06       Impact factor: 5.958

Review 6.  Risks of proteinuria and hypertension with bevacizumab, an antibody against vascular endothelial growth factor: systematic review and meta-analysis.

Authors:  Xiaolei Zhu; Shenhong Wu; William L Dahut; Chirag R Parikh
Journal:  Am J Kidney Dis       Date:  2007-02       Impact factor: 8.860

7.  Matrix metalloproteinase-2 is elevated in the plasma of women with preeclampsia.

Authors:  H Narumiya; Y Zhang; C Fernandez-Patron; L J Guilbert; S T Davidge
Journal:  Hypertens Pregnancy       Date:  2001       Impact factor: 2.108

8.  Autoantibodies to the angiotensin type I receptor in response to placental ischemia and tumor necrosis factor alpha in pregnant rats.

Authors:  Babbette LaMarca; Gerd Wallukat; Mayte Llinas; Florian Herse; Ralf Dechend; Joey P Granger
Journal:  Hypertension       Date:  2008-10-13       Impact factor: 10.190

9.  Hypertension in response to autoantibodies to the angiotensin II type I receptor (AT1-AA) in pregnant rats: role of endothelin-1.

Authors:  Babbette LaMarca; Marc Parrish; Lillian Fournier Ray; Sydney R Murphy; Lyndsay Roberts; Porter Glover; Gerd Wallukat; Katrin Wenzel; Kathy Cockrell; James N Martin; Michael J Ryan; Ralf Dechend
Journal:  Hypertension       Date:  2009-08-24       Impact factor: 10.190

10.  Pharmacological knockout of endothelin ET(A) receptors.

Authors:  Takanobu Taniguchi; Ikunobu Muramatsu
Journal:  Life Sci       Date:  2003-12-05       Impact factor: 5.037

View more
  27 in total

Review 1.  Effect of low birth weight on women's health.

Authors:  Barbara T Alexander; John Henry Dasinger; Suttira Intapad
Journal:  Clin Ther       Date:  2014-07-23       Impact factor: 3.393

2.  The anti-aging factor α-klotho during human pregnancy and its expression in pregnancies complicated by small-for-gestational-age neonates and/or preeclampsia.

Authors:  Jezid Miranda; Roberto Romero; Steven J Korzeniewski; Alyse G Schwartz; Piya Chaemsaithong; Tamara Stampalija; Lami Yeo; Zhong Dong; Sonia S Hassan; George P Chrousos; Philip Gold; Tinnakorn Chaiworapongsa
Journal:  J Matern Fetal Neonatal Med       Date:  2013-08-19

3.  Angiogenic imbalance and diminished matrix metalloproteinase-2 and -9 underlie regional decreases in uteroplacental vascularization and feto-placental growth in hypertensive pregnancy.

Authors:  Carlos A Dias-Junior; Juanjuan Chen; Ning Cui; Charles L Chiang; Minglin Zhu; Zongli Ren; Jose S Possomato-Vieira; Raouf A Khalil
Journal:  Biochem Pharmacol       Date:  2017-09-11       Impact factor: 5.858

4.  The profiles of soluble adhesion molecules in the "great obstetrical syndromes".

Authors:  Nikolina Docheva; Roberto Romero; Piya Chaemsaithong; Adi L Tarca; Gaurav Bhatti; Percy Pacora; Bogdan Panaitescu; Noppadol Chaiyasit; Tinnakorn Chaiworapongsa; Eli Maymon; Sonia S Hassan; Offer Erez
Journal:  J Matern Fetal Neonatal Med       Date:  2018-02-01

5.  Sildenafil Treatment Ameliorates the Maternal Syndrome of Preeclampsia and Rescues Fetal Growth in the Dahl Salt-Sensitive Rat.

Authors:  Ellen E Gillis; Jennifer N Mooney; Michael R Garrett; Joey P Granger; Jennifer M Sasser
Journal:  Hypertension       Date:  2016-01-04       Impact factor: 10.190

6.  Hypertension, inflammation and T lymphocytes are increased in a rat model of HELLP syndrome.

Authors:  Kedra Wallace; Rachael Morris; Patrick B Kyle; Denise Cornelius; Marie Darby; Jeremy Scott; Janae Moseley; Krystal Chatman; Babbette Lamarca
Journal:  Hypertens Pregnancy       Date:  2014-02       Impact factor: 2.108

Review 7.  Preeclampsia and Pregnancy-Related Hypertensive Disorders.

Authors:  S Ananth Karumanchi; Joey P Granger
Journal:  Hypertension       Date:  2015-12-22       Impact factor: 10.190

Review 8.  Emerging drugs for preeclampsia--the endothelium as a target.

Authors:  Jennifer M Sasser; Sydney R Murphy; Joey P Granger
Journal:  Expert Opin Emerg Drugs       Date:  2015-07-03       Impact factor: 4.191

9.  Maternal plasma soluble TRAIL is decreased in preeclampsia.

Authors:  Piya Chaemsaithong; Tinnakorn Chaiworapongsa; Roberto Romero; Steven J Korzeniewski; Tamara Stampalija; Nandor Gabor Than; Zhong Dong; Jezid Miranda; Lami Yeo; Sonia S Hassan
Journal:  J Matern Fetal Neonatal Med       Date:  2013-08-13

Review 10.  Endothelin, kidney disease, and hypertension.

Authors:  Joshua S Speed; David M Pollock
Journal:  Hypertension       Date:  2013-04-22       Impact factor: 10.190

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.